32.42
+0.13
+(0.40%)
At close: January 31 at 3:29:02 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 8 | 13 | 13 |
Avg. Estimate | 175.85M | 181.01M | 664.96M | 767.02M |
Low Estimate | 173M | 172.7M | 644.4M | 730.7M |
High Estimate | 178.68M | 184.25M | 677.79M | 792.4M |
Year Ago Sales | 155.78M | 160.58M | 583.14M | 664.96M |
Sales Growth (year/est) | 12.88% | 12.72% | 14.03% | 15.35% |
EPS Trend
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
YR8.F | -- | -- | -- | -- |
S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
Reiterates | JMP Securities: Market Perform to Market Perform | 12/16/2024 |
Downgrade | JMP Securities: Market Outperform to Market Perform | 6/6/2024 |
Downgrade | Scotiabank: Sector Outperform to Sector Perform | 4/25/2024 |
Maintains | Piper Sandler: Neutral to Neutral | 4/25/2024 |
Downgrade | Needham: Buy to Hold | 4/25/2024 |
Downgrade | Truist Securities: Buy to Hold | 4/25/2024 |